Product Information
ABSORICA LD 32 MG CAPSULE is a brand product labeled by Sun Pharmaceutical Industries Inc., priced at $42.4342 per EA under NDC 10631000731. Its NADAC has been published 123 times since Apr 17, 2024.
FDA first approved this application on Nov 5, 2019.
The High Outlier badge above means this manufacturer's average price in the isotretinoin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
32 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
10631000731
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ISOTRETINOINApproval Type
New Drug (NDA)
FDA Application
NDA211913FDA Approved
11/5/2019
On Market Since
11/20/2019
Pharmacological Classes
Price Statistics
The NADAC for ABSORICA LD 32 MG CAPSULE has been published 123 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $42.4342 per EA |
|---|---|
| All-time high | $42.4422 (Jan 15, 2025) |
| All-time low | $41.3154 (Aug 20, 2025) |
| 52-week high | $42.4342 |
| 52-week low | $41.3154 |
| Median price | $42.0267 |
| Average price | $42.0459 |
| Largest weekly change | +1.0% (Aug 19, 2026) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the isotretinoin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ABSORICA LD 32 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ABSORICA LD 32 MG CAPSULE, manufactured by Sun Pharmaceutical Industries Inc., is $42.4342 per EA (NDC 10631000731), effective Aug 19, 2026.
How has the price of ABSORICA LD 32 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ABSORICA LD 32 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for ABSORICA LD 32 MG CAPSULE?
Since Apr 17, 2024, the NADAC for ABSORICA LD 32 MG CAPSULE has ranged from a low of $41.3154 (Aug 20, 2025) to a high of $42.4422 (Jan 15, 2025), with a median of $42.0267 per EA.
Are there cheaper alternatives to ABSORICA LD 32 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of ABSORICA LD 32 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ABSORICA LD 32 MG CAPSULE?
ABSORICA LD 32 MG CAPSULE (NDC 10631000731) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a brand product.